Surgery or Balloon Angioplasty for Peripheral Vascular Disease: A Randomized Clinical Trial

Wolf, Gerald; Wilson, Samuel E.; Cross, Anne; Deupree, Robert H.; Stason, William B.

doi:10.1016/s1051-0443(93)71939-9

Cited by 164 publications

(17 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…2 Although generally thought to be inferior to surgical reconstruction, the only randomized clinical trial comparing angioplasty with surgery from the Veterans' Administration Cooperative Study failed to demonstrate a significant advantage for either procedure in the treatment of iliac arteries. 16 In particular, the life-table curves of patients treated for rest pain were superimposed at 3 years for the surgery and angioplasty groups, although the patency rate was only 60%. Our results are similar, with a 3-year clinical patency of 54% in our patients, most of whom were treated for limbthreatening ischemia.…”

Section: Discussionmentioning

confidence: 99%

Endovascular Therapy of Iliac Arteries: Routine Application of Intraluminal Stents Does Not Improve Clinical Patency

Cambria

Farooq

Mewissen

et al. 1999

Annals of Vascular Surgery

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Endovascular Therapy of Iliac Arteries: Routine Application of Intraluminal Stents Does Not Improve Clinical Patency

Cambria

Farooq

Mewissen

et al. 1999

Annals of Vascular Surgery

View full text Add to dashboard Cite

“…A randomized clinical study comparing percutaneous transluminal angioplasty and bypass surgery for iliac or femoropopliteal disease with claudication or rest ischemia, concluded that there was no significant difference in outcome after a median of 4 years regardless of the revascularization strategy. 35 Surgical revascularization is performed for lesions not amenable to angioplasty and when long segments of the vessel are involved. Bypass can be performed using autologous (saphenous vein graft) or synthetic grafts (dacron and polytetrafluroethylene).…”

Section: Revascularizationmentioning

confidence: 99%

Peripheral Arterial Disease—What Do We Need to Know?

Shanmugasundaram

Ram

Luft

et al. 2011

Clinical Cardiology

View full text Add to dashboard Cite

Peripheral artery disease (PAD) results from progressive narrowing of arteries secondary to atherosclerosis and is defined as an Ankle Brachial Index of <0.9. PAD is highly prevalent and is an increasing burden on both the economy and the patient, especially given the rapid shift in demographics in the United States. Despite its prevalence and association with cardiovascular disease, PAD is still underdiagnosed and undertreated. This may, in part, be related to lack of recognition from the physician's side or paucity of evidence from clinical trials. It has been shown that medical therapy approved for cardiovascular disease is effective in the treatment of PAD and decreases cardiovascular events. Various revascularization strategies are also available for improving symptoms and quality of life in these patients, yet they are underutilized. In an attempt to increase its recognition, PAD has been considered a coronary artery disease equivalent. This article reviews the diagnosis and management of PAD. © 2011 Wiley Periodicals, Inc.The authors have no funding, financial relationships, or conflicts of interest to disclose.

show abstract

“…People with claudication or rest pain in the general population treated with bypass and angioplasty reported improved functional status in several descriptive studies (167). A study of Veterans Administration general population patients with claudication or rest pain randomized to angioplasty or bypass surgery found equal improvement in the quality of life and functional status (168). A subanalysis of patients with diabetes was not possible because of the small sample size.…”

Section: Peripheral Vascular Diseasementioning

confidence: 99%